Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.

Toshiaki Ohkuma Min JunMark WoodwardSophia ZoungasMark E CooperDiederick E GrobbeePavel HametGiuseppe ManciaBryan WilliamsPaul WelshNaveed SattarJonathan E ShawKazem RahimiJohn Chalmersnull null

Published in: Diabetes care (2017)

Only NT-proBNP strongly and consistently improved the prediction of heart failure in patients with type 2 diabetes beyond a wide range of clinical risk factors and biomarkers.

Keyphrases

heart failure
risk factors
left ventricular
cardiac resynchronization therapy
acute heart failure
clinical trial
study protocol
atrial fibrillation
phase iii
phase ii
heat stress